Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Sources Sought opportunity from Department Of Health And Human Services was posted on June 30, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

NIH Brain Development Cohorts Biobank

Closed
75N98026R00106Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
FDA Office Of Acq Grant Svcs

POSTED

about 23 hours ago

DEADLINE

in 5 days
NAICS: 541714
New
Federal
Hypoxia Chamber Services
Solicitation # 80JSC026Q0008
NASA Johnson Space Center is soliciting combined synopsis and request for quotations under solicitation 80JSC026Q0008 for Hypoxia Chamber Services to support the Artemis Program. The objective is to investigate the physiological, cognitive, and clinical effects of mild hypobaric hypoxia through two 7-day test protocols involving continuous habitation for six subjects at air equivalent altitudes of 7,000 and 9,500 feet. The scope of work encompasses the provision of infrastructure, personnel, training, materials, and operational support. The contract is structured as a firm fixed price agreement with a base period from September 15, 2026, to September 30, 2027, and multiple option periods extending through March 1, 2030. The acquisition is open to all responsible sources under NAICS code 541714, with a size standard of 1,000 employees. Evaluation is based on a trade-off process where technical acceptability and past performance are significantly more important than price. Proposals must be submitted via email to the designated points of contact by October 1, 2026, following an extension granted in Amendment 0004. Key requirements include the submission of FAR 52.212-3 representations and certifications and adherence to specific submission criteria regarding team qualifications and risk assessment. The contract also incorporates strict guidelines regarding the protection of sensitive information and restrictions on funding activities with China.
NASA Johnson Space Center

POSTED

2 days ago

DEADLINE

in 19 days
NAICS: 541714
New
Federal
Hypobaric Chamber Pilot Studies
Solicitation # 80JSC026Q0006
NASA Johnson Space Center is soliciting quotes under solicitation 80JSC026Q0006 for pilot hypobaric chamber testing facilities to support decompression sickness research. The primary objective is to validate non-NASA resources for safe prebreathe procedures and extravehicular activity to support Artemis mission planning. The base requirement consists of three test days, with a minimum of two subjects per day, collecting and recording data according to research protocols. The contract also includes six optional work items, including additional test days, inflight-like treatment preparation, elevated metabolic rate testing, pharmaceutical-enhanced prebreathe, and body temperature studies. The base period of performance runs from September 1, 2026, to September 30, 2027, with various option periods extending through March or September 2029. This is a small business set-aside acquisition under NAICS code 541714. Awards will be made based on a trade-off analysis where technical acceptability and past performance are significantly more important than price. Technical evaluation focuses on facility capabilities, medical support, team expertise, and the proposed schedule for subject throughput. Offerors must provide a price quotation using the provided pricing sheet, and quotes must remain valid for at least 90 days. Following several amendments, the final deadline for the submission of offers is October 1, 2026, at 1:00 p.m. Central Time. All submissions must be sent electronically to the designated points of contact.
NASA Johnson Space Center

POSTED

2 days ago

DEADLINE

in 19 days

AI Contract Overview

Show more

The National Institute on Drug Abuse (NIH) is seeking qualified organizations to manage the NIH Brain Development Cohorts Biobank, a large-scale repository housing over 550,000 de-identified biological samples and associated data from the Adolescent Brain Cognitive Development and HEALthy Brain and Child Development studies. Vendors must demonstrate proven experience in handling high volumes of diverse biospecimens—including blood, saliva, DNA, RNA, placental tissue, and fecal matter—under varying storage conditions, with robust quality control and auditable Laboratory Information Management Systems. The contract requires managing sample collection through 48 national research sites, providing barcoded kits, training staff, maintaining chain of custody, resolving data discrepancies, and distributing samples to approved investigators in a cost-effective manner. The biobank must support a continuous influx of approximately 170,000 additional samples over the contract term. Technical and informatics responsibilities include maintaining and enhancing a web-based biobank portal with features such as sample inventory tracking, kit ordering, biospecimen access queries, and impact reporting, all while ensuring FISMA-low compliance and maintaining active ATO documentation. The vendor must also develop and sustain secure APIs and cyberinfrastructure for interoperable data exchange, manage databases linking phenotypic and genotypic information to sample identifiers, and ensure system stability through backend development, microservices, and PostgreSQL database maintenance. Laboratory requirements include scientific leadership with biobanking expertise, readiness to deliver CLIA-certified high-throughput analyses via direct capability or subcontractors if needed, and the ability to evaluate researcher inquiries with scientific rigor. Organizations must collaborate closely with the ABCD and HBCD Data Centers, co-sign the Specimen Transfer Agreement, and comply with federal confidentiality protections under 45 CFR Part 75 and the Public Health Service Act. Proposals must detail relevant experience, personnel qualifications, facility capabilities, business size and status, SAM.gov UEI, and business certifications—all submitted electronically by July 14, 2026, to the designated point of contact. This is a sources sought notice, not a request for proposals, and responses will not be compensated or guaranteed to lead to a contract award.

General Info

NIDA seeks small businesses to manage NIH biobank with 720K+ biospecimens, LIMS, secure data systems, and CLIA-capable genomic analysis.

Agency

Department Of Health And Human Services → National Institutes Of Health NidaView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

MD

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

1 update
PhaseClosed
Posted

Sources Sought

Amendment 1

Contract was updated

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Nida
Contacts2 people available
OfficeBethesda, MD, 20892, USA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Nida
View Agency Profile
Office AddressBethesda, MD, 20892, USA

Full Description

Show more

SOURCES SOUGHT NOTICE


The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is seeking capability statements from business organizations to provide the Government a resource that can maintain the NIH Brain Development Cohorts (NBDC) Biobank, a repository to process, store, analyze, and distribute de-identified biological samples and related data from the Adolescent Brain Cognitive DevelopmentSM (ABCD) Study and HEALthy Brain and Child Development (HBCD) Study.


Capable Vendors must demonstrate the experience and capability necessary to manage a large biobank containing over 550,000 samples, which would be transferred at the outset of the award, if other than the incumbent. Capable Vendors must demonstrate the ability to receive a volume of approximately 170,000 samples over the course of the contract.


Sample and Data Management


  1. Demonstrate an ability to safely process, store, and track between 500,000-700,000 biospecimen samples from a wide range of biospecimen types (e.g. blood, serum, plasma, DNA, RNA, saliva, hair, urine, teeth, fecal matter, placenta, umbilical cord blood and tissue) at a variety of storage conditions, and perform expert quality control and assurance procedures;
  2. Provide 48 research sites across the country with collection kits including barcoded tubes with human readable labels for the collection of biospecimens which will be registered and tracked in the Contractor’s auditable Laboratory Information Management System (LIMS). Provide site coordinators and research staff with training for ordering supplies and collecting samples;
  3. Maintain positive chain of custody and resolve data/sample discrepancies (e.g. missing data, incorrect information, samples sent to the wrong location) through management and support of issue tracking and resolution. This involves coordination with sites, site monitors, study staff, and the respective receiving or data management teams at the Biobank.
  4. Centrally manage and effectively distribute biosamples in the repository to qualified investigators approved through the Biospecimens Access Programs in a cost-effective manner;

Technical & Informatics Requirements


  1. Maintain and update databases linking phenotypic/genotypic information with participant and sample IDs;
  2. Manage and enhance the NBDC Biobank portal (both front-end and back-end) to support all currently available features and provide updates and improvements when requested. Requirements include, but are not limited to:
    1. Maintain and update existing databases to accurately reflect available samples, and synchronize this data with the Biospecimen Explorer front-end
    2. Provide for the ordering of kits and supplies for the ABCD and HBCD Study staff
    3. Support the Biospecimen Access Program features (e.g. Biospecimen Explorer, Availability Inquiry and Inquiry Dashboard, Resource Availability and Impact Reports)
    4. Maintain ATO and security documents to keep system compliant with FISMA-low and other NIH requirements;
  3. Maintain, update, and develop Application Programming Interfaces (APIs) and a cyberinfrastructure for secure, interoperable data exchange;

Laboratory Requirements


  1. Lead investigators and support staff must demonstrate experience in biobanking, LIMS and database management. Additional technical requirements include experience to maintain and further develop all aspects of the NBDC Biobank Portal (e.g. backend logic and server maintenance, creating microservices and PostGreSQL databases, website design and UI/UX);
  2. Provide scientific and technical expertise to evaluate and offer feedback to researcher-submitted availability inquiries for ABCD and HBCD biosamples.
  3. If requested, provide Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory capabilities (either directly or through subcontracts) for performing metabolic, hematologic, and/or cutting-edge, high-throughput genotyping, sequencing, and gene-expression analyses as needed;  ensure scientific leads have appropriate technical experience;

Collaboration & Governance


  1. Establish a strong collaborative relationship with the ABCD and HBCD Data Centers and study teams to enable modifications that may be required as the studies evolve;
  2. Be a co-signatory of the Specimen Transfer Agreement developed by NIDA; and
  3. Be eligible to receive a Certificate of Confidentiality, with adherence to requirements for protecting sensitive participant information as set forth in 45 CFR Part 75.303(a), NIHGPS Chapter 8.3 and15.2.1, and subsection 301(d) of the Public Health Service Act (see: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-17-109.html).

Interested organizations must demonstrate and document in the submitted capability statement extensive experience in the technical areas listed above. Furthermore, organizations should include relevant and specific information on each of the following qualifications:


1) Experience: An outline of previous similar projects, specifically the techniques employed in the areas described above.


2) Personnel: Name, professional qualifications of personnel with specific experience in the work requested and knowledge of, and experience in, the field of biomedical research.


3) Facilities: Availability and description of the facilities and equipment required to conduct this type of work.


The Government will assess the appropriateness of professional and technical personnel classifications.  The Government will consider any other specific and relevant information about this particular announcement that would improve our evaluation of respondents.  Organizations should demonstrate capability to administer and coordinate interrelated tasks in an effective and timely manner.  Documentation may include, but is not limited to, contracts in which the organization performed equivalent tasks (Government and commercial); references, i.e., names, titles, telephone numbers and any other information serving to document the organizations capability; and awards or commendations.


The established NAICS code is 541714: Research and Development in Biotechnology (except Nanobiotechnology). The U.S. Small Business Administration establishes a size standard for 541714 of 1,000 employees or fewer.


All capability statements also should include the following: 1) company name and address; 2) point of contact, 3) SAM.gov Unique Entity Identifier (UEI) 4) phone/fax/email; 5) NAICS Code(s), 6) business size and status; 7) capability information in response to the requirement and qualifications identified in this notice; and 8) type(s) of business, if any (e.g., small, Veteran-owned, service-disabled Veteran-Owned, women-owned, 8(a), Small Disadvantaged Business (SDB), and Historically Underutilized Business Zone (HUBZone).


THIS IS NOT A REQUEST FOR PROPOSALS: This notice is for information and planning purposes only and does not commit the Government to any contractual agreement. The Government does not intend to award a contract based on responses under this announcement nor otherwise pay for the preparation of any information sent for the Government’s use. Any proprietary information should be so marked. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate.  Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received to provide feedback to respondents with respect to any information submitted.


Based upon market research, the Government is not using the policies contained in Part 12, Acquisition of Commercial Items, in its solicitation for the described supplies or services. However, interested persons may identify to the Contracting Officer their interest and capability to satisfy the Government's requirement with a commercial item within 15 days of this notice.


Business concerns that believe they possess the capability necessary to successfully undertake the work described above must submit capability statements electronically to the Contract Specialist, Shaun Rostad at shaun.rostad@nih.gov,  NO LATER THAN 1:00 p.m. EST on July 14, 2026. The Subject line for the submission should include this Sources Sought Number.


NIDA will not accept paper or faxed capability statements.


More opportunities from Department Of Health And Human Services → National Institutes Of Health Nida

Same awarding agency

NAICS: 541990
Federal
Account Management, Planning, and Maintenance for Online Crowd-Sourced Surveys and Cognitive Tasks for Individuals
Solicitation # 75N98026Q01128
Solicitation 75N98026Q01128 is a Sources Sought notice issued by the National Institute of Mental Health to identify qualified small business sources capable of providing account management and participant recruitment for online crowd-sourced research. The objective is to collect survey and cognitive task responses from at least 2,720 individuals across four specific categories: adults with anxiety only, adults with depression only, adults with both conditions, and a control group with neither. Additionally, the contractor must provide at least 1,500 high-quality English-speaking adult respondents for tasks lasting up to 75 minutes, with a set participant compensation of 20 dollars per completion. This notice is for market research purposes to determine the availability of capable small businesses and to inform the government's acquisition method and potential set-aside decisions. Interested parties must submit a capability statement by September 16, 2022, detailing their technical qualifications, business size, and NAICS code 541990 classification. The government maintains unlimited rights to all deliverables, and the selected contractor will be responsible for managing participant reimbursement and providing the collected data and demographic information to the National Institute of Mental Health.
All Other Professional, Scientific, and Technical Services

POSTED

11 days ago

DEADLINE

in 4 days
View Details
NAICS: 541715
Federal
Medicinal Chemistry Support Program for Therapeutic Development (MCSP)
Solicitation # 75N98026R00144SB
This Small Business Sources Sought notice is issued by the National Institutes of Health to identify qualified small business sources capable of providing comprehensive medicinal chemistry services for the Medicinal Chemistry Support Program for Therapeutic Development. The government seeks a turn-key operation to support preclinical drug discovery efforts, including exploratory, hit-to-lead, and lead optimization phases. Required capabilities include SAR analysis and design, synthesis, in vitro ADMET studies, computational chemistry, and compound logistics. Vendors must demonstrate the capacity to manage one to ten concurrent projects and possess the necessary technical personnel and facilities to scale operations as needed. Interested small businesses under NAICS code 541715 must submit detailed responses by September 14, 2026, addressing their in-house capabilities, professional experience, and staffing qualifications. The government is using this notice to determine if the requirement can be set aside exclusively for small businesses and to evaluate whether the services should be classified as commercial or research and development. Responses should be emailed to the designated points of contact and must include the organization's Unique Entity Identifier and small business status. This notice is for research purposes only and is not a formal solicitation for proposals.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 1 month ago

DEADLINE

in 2 days
View Details
NAICS: 541715
Federal
Medicinal Chemistry Support Program for Therapeutic Development (MCSP)
Solicitation # 75N98026R00144
This Sources Sought notice is issued by the National Institutes of Health to identify qualified vendors capable of providing comprehensive medicinal chemistry services for the Medicinal Chemistry Support Program for Therapeutic Development. The government is seeking a full-service, turn-key operation to support preclinical drug discovery efforts, including exploratory, hit-to-lead, and lead optimization phases. Required capabilities include SAR analysis and design, synthesis, in vitro ADMET studies, computational chemistry, and compound logistics. Vendors must demonstrate the ability to manage between one and ten concurrent projects and provide detailed information regarding their staffing, facilities, and experience in advancing compounds toward Phase 1 clinical testing. The primary objective of this notice is to conduct market research to determine the availability of qualified sources and assess whether the requirement can be set aside for small businesses under NAICS code 541715. The government has preliminarily determined that these services are not commercial in nature, though vendors are encouraged to provide evidence if they believe the services are commercial. Interested parties must submit a detailed response by September 14, 2026, including their Unique Entity Identifier and business size status. This is not a solicitation for proposals, and the government is not responsible for any costs incurred during the response process.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 1 month ago

DEADLINE

in 2 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS